AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10962319 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 247
Study 8994123 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalamic hemorrhages
Number of subjects: 43
Study 8994123 — intervention group
Group type: COMPARATOR
Intervention: Putaminal hemorrhages
Number of subjects: 43
Study 8994123 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 43
Study 1309678 — intervention group
Group type: EXPERIMENTAL
Intervention: OK-432
Number of subjects: 53
Study 1309678 — intervention group
Group type: COMPARATOR
Intervention: mitomycin C
Number of subjects: 53
Study 3912974 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acyclovir (ACV)
Number of subjects: 68
Study 3912974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 31592875 — intervention group
Group type: EXPERIMENTAL
Intervention: Home hand strength focused exercise program (from 2 to 6 weeks after injury)
Number of subjects: 52
Study 31592875 — intervention group
Group type: COMPARATOR
Intervention: Finger range of motion exercises (control group)
Number of subjects: 52
Study 30054467 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 0
Study 30054467 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0
Study 27196464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonolysis during cardiac surgery
Number of subjects: 120
Study 27196464 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sonolysis)
Number of subjects: 120
Study 25140587 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity massage
Number of subjects: 29
Study 25140587 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity massage
Number of subjects: 29
Study 22276996 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nicotine patch (21-mg)
Number of subjects: 509
Study 22276996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study 20627247 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-month training program in HCh
Number of subjects: 40
Study 20627247 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-month training program in NL
Number of subjects: 40
Study 20627247 — intervention group
Group type: COMPARATOR
Intervention: No exercise program in HCh
Number of subjects: 40
Study 20627247 — intervention group
Group type: COMPARATOR
Intervention: No exercise program in NL
Number of subjects: 40
Study 17560421 — intervention group
Group type: EXPERIMENTAL
Intervention: Current medical therapies for adult CD and UC
Number of subjects: 0
Study 15863645 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-induced bronchoconstriction
Number of subjects: 0
Study 15863645 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 0
Study 11490060 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 9114777 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitalis with acebutolol
Number of subjects: 0
Study 9114777 — intervention group
Group type: COMPARATOR
Intervention: Digitalis without acebutolol
Number of subjects: 0
Study 1438105 — intervention group
Group type: EXPERIMENTAL
Intervention: Benfluorex (B)
Number of subjects: 0
Study 1438105 — intervention group
Group type: COMPARATOR
Intervention: Metformin (M)
Number of subjects: 0
Study 4065432 — intervention group
Group type: EXPERIMENTAL
Intervention: Good metabolic control (median blood glucose 4.7 mmol/L)
Number of subjects: 8
Study 4065432 — intervention group
Group type: COMPARATOR
Intervention: Poor metabolic control (median blood glucose 16.3 mmol/L)
Number of subjects: 8
Study 4065432 — intervention group
Group type: COMPARATOR
Intervention: Poor metabolic control
Number of subjects: 8
Study 29621947 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitch/Timbre group (melodic contour identification training using computer software)
Number of subjects: 0
Study 29621947 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy group (face-to-face group exercises including rhythm perception, musical speech perception, music perception, singing, vocal emotion identification, and music improvisation)
Number of subjects: 0
Study 29621947 — intervention group
Group type: COMPARATOR
Intervention: Control group (group nonmusic activities such as writing, cooking, and woodworking)
Number of subjects: 0
Study 27281084 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone 5 mg
Number of subjects: 100
Study 27281084 — intervention group
Group type: COMPARATOR
Intervention: Intravenous dexamethasone 5 mg
Number of subjects: 100
Study 23821970 — intervention group
Group type: EXPERIMENTAL
Intervention: Alumina-on-alumina ceramic bearings
Number of subjects: 116
Study 23821970 — intervention group
Group type: COMPARATOR
Intervention: Metal-on-conventional polyethylene
Number of subjects: 116
Study 21122269 — intervention group
Group type: EXPERIMENTAL
Intervention: Rességuier method (RM)
Number of subjects: 41
Study 21122269 — intervention group
Group type: COMPARATOR
Intervention: Observational Group (OG)
Number of subjects: 41
Study 18698266 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxious participants (n = 101)
Number of subjects: 101
Study 18698266 — intervention group
Group type: COMPARATOR
Intervention: Healthy youths (n = 51)
Number of subjects: 101
Study 16603748 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-family group intervention (26 sessions over 12 months)
Number of subjects: 59
Study 16603748 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study 14644293 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 202
Study 14644293 — intervention group
Group type: COMPARATOR
Intervention: Focused attention
Number of subjects: 202
Study 14644293 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 202
Study 10941887 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Field (PEMF) therapy, n = 22
Number of subjects: 61
Study 10941887 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Current (DC) electrical stimulation, n = 17
Number of subjects: 61
Study 10941887 — intervention group
Group type: COMPARATOR
Intervention: Control group, n = 22
Number of subjects: 61
Study 8937760 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (desogestrel+ethinyloestradiol)
Number of subjects: 19
Study 8937760 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (levonorgestrel and ethinyloestradiol)
Number of subjects: 19
Study 8937760 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-pregnant women not using contraceptives)
Number of subjects: 19
Study 1576638 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (n = 11)
Number of subjects: 20
Study 1576638 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride (n = 12)
Number of subjects: 20
Study 1576638 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 20
Study 3096681 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (20 mg) + Methadone (100% of maintenance dose)
Number of subjects: 5
Study 3096681 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (40 mg) + Methadone (100% of maintenance dose)
Number of subjects: 5
Study 3096681 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (20 mg) + Methadone (150% of maintenance dose)
Number of subjects: 5
Study 3096681 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (40 mg) + Methadone (150% of maintenance dose)
Number of subjects: 5
Study 3096681 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Methadone (100% of maintenance dose)
Number of subjects: 5
Study 3096681 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Methadone (150% of maintenance dose)
Number of subjects: 5
Study 29222891 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (50 g/278 mL, p.o.) 2 h before anaesthesia induction
Number of subjects: 23
Study 29222891 — intervention group
Group type: COMPARATOR
Intervention: Mineral water (control)
Number of subjects: 23
Study 27219115 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (once daily for 5 consecutive days starting on postoperative day 1, at 16 acupoints)
Number of subjects: 10
Study 27219115 — intervention group
Group type: COMPARATOR
Intervention: Nonacupuncture (no treatment)
Number of subjects: 10
Study 27219115 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 10
Study 25481809 — intervention group
Group type: EXPERIMENTAL
Intervention: Various OA treatments (pharmacological and non-pharmacological)
Number of subjects: 537
Study 25481809 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy for knee OA
Number of subjects: 537
Study 25481809 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy for hip OA
Number of subjects: 537
Study 25481809 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of knee brace with metal supports
Number of subjects: 537
Study 22284848 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoarthritis of the Knee Self‐Management Program (OAK)
Number of subjects: 146
Study 22284848 — intervention group
Group type: COMPARATOR
Intervention: Control group (6-month waiting period)
Number of subjects: 146
Study 20451804 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary flow reserve (CFR) measurement by transthoracic Doppler echocardiography (TTDE)
Number of subjects: 175
Study 20451804 — intervention group
Group type: EXPERIMENTAL
Intervention: CFR value < 2.0
Number of subjects: 175
Study 20451804 — intervention group
Group type: EXPERIMENTAL
Intervention: CFR assessment in left anterior descending coronary artery
Number of subjects: 175
Study 20451804 — intervention group
Group type: EXPERIMENTAL
Intervention: CFR assessment in right coronary artery
Number of subjects: 175
Study 20451804 — intervention group
Group type: EXPERIMENTAL
Intervention: CFR assessment in left circumflex coronary artery
Number of subjects: 175
Study 18025524 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptidic erythropoiesis receptor agonist at doses of 0.025, 0.05, and 0.1 mg/kg
Number of subjects: 0
Study 18025524 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptidic erythropoiesis receptor agonist
Number of subjects: 0
Study 18468569 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adhesiolysis
Number of subjects: 0
Study 18468569 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic laparoscopy
Number of subjects: 0
Study 15886445 — intervention group
Group type: EXPERIMENTAL
Intervention: Right lateral decubitus position
Number of subjects: 0
Study 11676992 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained maximal voluntary isometric contraction (MVIC) of elbow flexors, knee extensors, and ankle dorsiflexors for 30 seconds
Number of subjects: 54
Study 11676992 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects performing the same MVIC
Number of subjects: 54
Study 9460311 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction with intravenous oxytocin
Number of subjects: 5041
Study 9460311 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction with vaginal prostaglandin E2 gel
Number of subjects: 5041
Study 9460311 — intervention group
Group type: COMPARATOR
Intervention: Expectant management followed by induction with oxytocin
Number of subjects: 5041
Study 9460311 — intervention group
Group type: COMPARATOR
Intervention: Expectant management followed by induction with prostaglandin E2 gel
Number of subjects: 5041
Study 9460311 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction groups (both types)
Number of subjects: 5041
Study 9460311 — intervention group
Group type: COMPARATOR
Intervention: Expectant management groups
Number of subjects: 5041
Study 8194610 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ultrasound and serum hCG determinations performed between 20 and 30 days after conception.
Number of subjects: 0
Study 3317352 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms dose per injection
Number of subjects: 314
Study 3317352 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 micrograms dose per injection
Number of subjects: 314
Study 12444268 — intervention group
Group type: EXPERIMENTAL
Intervention: Canine lacebacks
Number of subjects: 35
Study 12444268 — intervention group
Group type: COMPARATOR
Intervention: No canine lacebacks
Number of subjects: 35
Study 12444268 — intervention group
Group type: EXPERIMENTAL
Intervention: Canine lacebacks and No canine lacebacks
Number of subjects: 35
Study 31424302 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric calendar intervention (used by 15 participants)
Number of subjects: 27
Study 31424302 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group with 12 participants)
Number of subjects: 27
Study 31424302 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric calendar intervention
Number of subjects: 27
Study 30202927 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week group workshop on cognitive-behavioral coping skills
Number of subjects: 92
Study 30202927 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (self-help materials for BP reduction and physician referral)
Number of subjects: 92
Study 27283332 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple DMARD therapy with glucocorticoid bridging
Number of subjects: 159
Study 27283332 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate monotherapy with glucocorticoid bridging
Number of subjects: 159
Study 27283332 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering csDMARDs
Number of subjects: 159
Study 27283332 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering bDMARDs
Number of subjects: 159
Study 24828091 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted implementation strategy
Number of subjects: 1649
Study 22885329 — intervention group
Group type: EXPERIMENTAL
Intervention: ALFSG index (based on M30 levels and clinical variables)
Number of subjects: 250
Study 22885329 — intervention group
Group type: COMPARATOR
Intervention: King's College criteria (KCC)
Number of subjects: 250
Study 22885329 — intervention group
Group type: COMPARATOR
Intervention: Model for End Stage Liver Disease (MELD)
Number of subjects: 250
Study 20117031 — intervention group
Group type: EXPERIMENTAL
Intervention: AGHO (hyperoxygenated fatty acids)
Number of subjects: 148
Study 20117031 — intervention group
Group type: COMPARATOR
Intervention: Mepentol (control)
Number of subjects: 148
Study 20117031 — intervention group
Group type: COMPARATOR
Intervention: Comparison of AGHO and Mepentol
Number of subjects: 148
Study 19186857 — intervention group
Group type: EXPERIMENTAL
Intervention: Root canal therapy bypassing broken instruments (test group)
Number of subjects: 32
Study 19186857 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional root canal therapy (conventional therapy group)
Number of subjects: 32
Study 19186857 — intervention group
Group type: COMPARATOR
Intervention: Control group (not bypassing broken instruments)
Number of subjects: 32
Study 16438239 — intervention group
Group type: EXPERIMENTAL
Intervention: Twisting strength measured with a device
Number of subjects: 77
Study 14610985 — intervention group
Group type: EXPERIMENTAL
Intervention: CATCH program implemented in 18 Title I pilot schools
Number of subjects: 108
Study 10506877 — intervention group
Group type: EXPERIMENTAL
Intervention: Pristinamycin, 2 g/d for 8 days
Number of subjects: 310
Study 10506877 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime axetil, 500 mg/d
Number of subjects: 310
Study 7493787 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate active exercises
Number of subjects: 62
Study 7493787 — intervention group
Group type: COMPARATOR
Intervention: Immobilization in a plaster
Number of subjects: 62
Study 1951871 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin subcutaneously
Number of subjects: 97
Study 1951871 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) intravenously
Number of subjects: 97
Study 1951871 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 97
Study 6782606 — intervention group
Group type: EXPERIMENTAL
Intervention: Secobarbital 1.47 mg/kg
Number of subjects: 0
Study 6782606 — intervention group
Group type: EXPERIMENTAL
Intervention: Secobarbital 2.94 mg/kg
Number of subjects: 0
Study 6782606 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 0
Study 31719552 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 days of 6 degrees head-down tilt bed rest
Number of subjects: 0
Study 31719552 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 29522529 — intervention group
Group type: EXPERIMENTAL
Intervention: Postal intervention (pedometer, handbooks, PA diaries)
Number of subjects: 1231
Study 29522529 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse support intervention (pedometer, handbooks, PA diaries)
Number of subjects: 1231
Study 29522529 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse support intervention (PACE-Lift)
Number of subjects: 1231
Study 29522529 — intervention group
Group type: COMPARATOR
Intervention: Control group (PACE-UP)
Number of subjects: 1231
Study 29522529 — intervention group
Group type: COMPARATOR
Intervention: Control group (PACE-Lift)
Number of subjects: 1231
Study 26790144 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN 13 months
Number of subjects: 1388
Study 26790144 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN 25 months
Number of subjects: 1388
Study 26790144 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1388
Study 26790144 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage IIB/III-N1 with ulcerated melanoma IFN 13 months
Number of subjects: 1388
Study 26790144 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage IIB/III-N1 with ulcerated melanoma IFN 25 months
Number of subjects: 1388
Study 26790144 — intervention group
Group type: COMPARATOR
Intervention: Stage IIB/III-N1 with ulcerated melanoma Observation
Number of subjects: 1388
Study 24820290 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion-aftereffect (MAE) induced eye movements
Number of subjects: 17
Study 24820290 — intervention group
Group type: EXPERIMENTAL
Intervention: MAE induced eye movements
Number of subjects: 17
Study 24820290 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternystagmus (ASOKN)
Number of subjects: 17
Study 24820290 — intervention group
Group type: EXPERIMENTAL
Intervention: High-brightness stimuli
Number of subjects: 17
Study 24820290 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-brightness stimuli
Number of subjects: 17
Study 22648445 — intervention group
Group type: COMPARATOR
Intervention: Anterior colporrhaphy
Number of subjects: 44
Study 22648445 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft polypropylene mesh (GYNEMESH*PS, Gynecare, Ethicon, France)
Number of subjects: 44
Study 20667262 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation program (mindfulness)
Number of subjects: 0
Study 20667262 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 18591361 — intervention group
Group type: EXPERIMENTAL
Intervention: Print and telephone intervention
Number of subjects: 966
Study 18591361 — intervention group
Group type: COMPARATOR
Intervention: Contact comparison group
Number of subjects: 966
Study 15795697 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD patients
Number of subjects: 84
Study 15795697 — intervention group
Group type: EXPERIMENTAL
Intervention: IPF patients
Number of subjects: 84
Study 15795697 — intervention group
Group type: COMPARATOR
Intervention: IPF sera
Number of subjects: 84
Study 15530692 — intervention group
Group type: EXPERIMENTAL
Intervention: Connaught high titer vaccine (CN)
Number of subjects: 111
Study 15530692 — intervention group
Group type: COMPARATOR
Intervention: Meningococcal A + C vaccine (MEN)
Number of subjects: 111
Study 12578106 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium administered within 1‐15 seconds
Number of subjects: 60
Study 12578106 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium administered within 15‐30 seconds
Number of subjects: 60
Study 12578106 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium administered within 30‐60 seconds
Number of subjects: 60
Study 12578106 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium administration
Number of subjects: 60
Study 9194141 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg)
Number of subjects: 24
Study 9194141 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride (100 mg)
Number of subjects: 24
Study 9194141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1524684 — intervention group
Group type: EXPERIMENTAL
Intervention: SofScale Scaling Gel
Number of subjects: 15
Study 1524684 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated quadrants)
Number of subjects: 15
Study 3893624 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 per cent sodium hypochlorite
Number of subjects: 43
Study 3893624 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 per cent povidone-iodine
Number of subjects: 43
Study 3893624 — intervention group
Group type: COMPARATOR
Intervention: 0.9 per cent saline
Number of subjects: 43
Study 31851351 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT with celecoxib (200 mg twice daily)
Number of subjects: 96
Study 31851351 — intervention group
Group type: COMPARATOR
Intervention: CCRT alone
Number of subjects: 96
Study 31851351 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT with celecoxib
Number of subjects: 96
Study 31851351 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT with celecoxib among high-risk genotype patients
Number of subjects: 96
Study 31851351 — intervention group
Group type: COMPARATOR
Intervention: CCRT alone among high-risk genotype patients
Number of subjects: 96
Study 29967797 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsuccessful dietary restrained group
Number of subjects: 120
Study 29967797 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful dietary restrained group
Number of subjects: 120
Study 29967797 — intervention group
Group type: COMPARATOR
Intervention: Reference group
Number of subjects: 120
Study 26542030 — intervention group
Group type: EXPERIMENTAL
Intervention: Any treatment (including chemotherapy, surgery, or radiotherapy)
Number of subjects: 98
Study 26542030 — intervention group
Group type: EXPERIMENTAL
Intervention: Local treatment (surgery and/or radiotherapy)
Number of subjects: 98